Skip to main content
. 2021 Oct 21;2021(10):CD001146. doi: 10.1002/14651858.CD001146.pub6

Comparison 1. Mortality at different ages.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Neonatal mortality (up to 28 days) 20 2933 Risk Ratio (M‐H, Fixed, 95% CI) 1.01 [0.87, 1.18]
1.1.1 Dexamethasone 16 2576 Risk Ratio (M‐H, Fixed, 95% CI) 1.05 [0.90, 1.23]
1.1.2 Hydrocortisone 4 357 Risk Ratio (M‐H, Fixed, 95% CI) 0.77 [0.49, 1.21]
1.2 Mortality at 36 weeks 27 4176 Risk Ratio (M‐H, Fixed, 95% CI) 1.01 [0.90, 1.13]
1.2.1 Dexamethasone 17 2791 Risk Ratio (M‐H, Fixed, 95% CI) 1.08 [0.94, 1.23]
1.2.2 Hydrocortisone 10 1385 Risk Ratio (M‐H, Fixed, 95% CI) 0.85 [0.67, 1.06]
1.3 Mortality to hospital discharge 29 4164 Risk Ratio (M‐H, Fixed, 95% CI) 0.96 [0.85, 1.07]
1.3.1 Dexamethasone 18 2731 Risk Ratio (M‐H, Fixed, 95% CI) 1.03 [0.90, 1.19]
1.3.2 Hydrocortisone 11 1433 Risk Ratio (M‐H, Fixed, 95% CI) 0.80 [0.65, 0.99]
1.4 Mortality at latest reported age 31 4373 Risk Ratio (M‐H, Fixed, 95% CI) 0.95 [0.85, 1.06]
1.4.1 Dexamethasone 20 2940 Risk Ratio (M‐H, Fixed, 95% CI) 1.02 [0.90, 1.16]
1.4.2 Hydrocortisone 11 1433 Risk Ratio (M‐H, Fixed, 95% CI) 0.80 [0.65, 0.99]